Role of IL-33 and its receptor in T cell-mediated autoimmune diseases
about
Application of the adverse outcome pathway (AOP) concept to structure the available in vivo and in vitro mechanistic data for allergic sensitization to food proteinsElevated Circulating Interleukin 33 Levels in Stable Renal Transplant Recipients at High Risk for Cardiovascular Events.Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma.A review on interleukins: The key manipulators in rheumatoid arthritis.Overexpression of interleukin-33 is associated with poor prognosis of patients with glioma.
P2860
Role of IL-33 and its receptor in T cell-mediated autoimmune diseases
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Role of IL-33 and its receptor in T cell-mediated autoimmune diseases
@ast
Role of IL-33 and its receptor in T cell-mediated autoimmune diseases
@en
type
label
Role of IL-33 and its receptor in T cell-mediated autoimmune diseases
@ast
Role of IL-33 and its receptor in T cell-mediated autoimmune diseases
@en
prefLabel
Role of IL-33 and its receptor in T cell-mediated autoimmune diseases
@ast
Role of IL-33 and its receptor in T cell-mediated autoimmune diseases
@en
P2860
P356
P1476
Role of IL-33 and its receptor in T cell-mediated autoimmune diseases
@en
P2093
Guangjie Chen
P2860
P304
P356
10.1155/2014/587376
P407
P577
2014-06-16T00:00:00Z